Examining Racial and Ethnic Inequities in Opioid Prescribing and Risk Screening Among Patients With Advanced Cancer

Rodin, Rebecca; Smith, Cardinale B.

doi:10.1200/jco.22.02879

Cited by 1 publication

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the consideration of the risks of opioid use is important, assessment without interference from socioeconomic or racial biases poses a significant challenge to clinical oncologists. It has been demonstrated that physicians’ implicit biases may lead to disproportionate pain undertreatment in vulnerable groups [ 65 , 66 , 67 ]. Risk assessment must therefore be carefully considered, and further developments which acknowledge the intrinsic biases with which providers approach shared decision-making opportunities are needed to improve these guidelines.…”

Section: What Are the Risks Of Opioid Use Among Advanced Cancer Patie...mentioning

confidence: 99%

The Stigma Surrounding Opioid Use as a Barrier to Cancer-Pain Management: An Overview of Experiences with Fear, Shame, and Poorly Controlled Pain in the Context of Advanced Cancer

Harsanyi,

Cuthbert,

Schulte

2023

Current Oncology

View full text Add to dashboard Cite

Cancer-related pain affects a majority of patients with advanced cancer and is often undertreated. The treatment of this pain is largely reliant on the use of opioids, which are essential medicines for symptom management and the maintenance of quality of life (QoL) for patients with advanced cancer. While there are cancer-specific guidelines for the treatment of pain, widespread publication and policy changes in response to the opioid epidemic have drastically impacted perceptions of opioid use. This overview therefore aims to investigate how manifestations of opioid stigma impact pain management in cancer settings, with an emphasis on the experiences of patients with advanced cancer. Opioid use has been widely stigmatized in multiple domains, including public, healthcare, and patient populations. Physician hesitancy in prescribing and pharmacist vigilance in dispensing were identified as barriers to optimal pain management, and may contribute to stigma in the context of advanced cancer. Evidence in the literature suggests that opioid stigma may result in patient deviations from prescription instructions, which generally leads to pain undertreatment. Patients reflected on experiencing shame and fear surrounding their prescription opioid use and feeling uncomfortable communicating with their healthcare providers on these topics. Our findings indicate that future work is required to educate patients and providers in order to de-stigmatize opioid use. Through alleviating stigma, patients may be better able to make decisions regarding their pain management which lead to freedom from cancer-related pain and improved QoL.

show abstract

Section: What Are the Risks Of Opioid Use Among Advanced Cancer Patie...mentioning

confidence: 99%

The Stigma Surrounding Opioid Use as a Barrier to Cancer-Pain Management: An Overview of Experiences with Fear, Shame, and Poorly Controlled Pain in the Context of Advanced Cancer

Harsanyi,

Cuthbert,

Schulte

2023

Current Oncology

View full text Add to dashboard Cite

show abstract

Examining Racial and Ethnic Inequities in Opioid Prescribing and Risk Screening Among Patients With Advanced Cancer

Cited by 1 publication

References 21 publications

The Stigma Surrounding Opioid Use as a Barrier to Cancer-Pain Management: An Overview of Experiences with Fear, Shame, and Poorly Controlled Pain in the Context of Advanced Cancer

The Stigma Surrounding Opioid Use as a Barrier to Cancer-Pain Management: An Overview of Experiences with Fear, Shame, and Poorly Controlled Pain in the Context of Advanced Cancer

Contact Info

Product

Resources

About